The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia

NCT07144592 | Recruiting

• 1 other identifier: 167678
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).

Conditions

SCHIZOPHRENIA 1 (Disorder); Psychosocial Adaptation; Treatment Adherence

Keywords

treatment adherence; Schizophrenia; solution-focused therapy,; psychiatric nursing

Outcome Measures

Primary Outcomes (2)

• pretest (6-week solution-focused approach before the intervention)

  1\. Psychosocial Adjustment (PSSAS) Description: Measured with the Psychosocial Adjustment Scale (PSSAS), which assesses social relationships, daily life management, and coping with stress. Scores range from 0 to 180; higher scores indicate better psychosocial adjustment. Time Frame: Baseline (within 1 week before intervention) Unit of Measure: Total score (0-180)

  Baseline (1 week before intervention)]

• pretest (6-week solution-focused approach before the intervention)

  2\. Medication Adherence (MARS) Description: Measured with the Medication Adherence Scale (MARS), which assesses adherence to prescribed pharmacological treatment. Scores range from 0 to 10; higher scores indicate better medication adherence. Time Frame: Baseline (within 1 week before intervention) Unit of Measure: Total score (0-10)

  Baseline (within 1 week before intervention)

Secondary Outcomes (2)

• posttest (After the 6-week solution-focused approach intervention)

  6 weeks after baseline (post-intervention)

• posttest (After the 6-week solution-focused approach intervention)

  Post-intervention (6 weeks after completion of the intervention)

Study Arms (2)

experimental group (Solution-Focused Approach Program)

EXPERIMENTAL

A 6-week solution-focused approach program will be applied to the experimental group.

Behavioral: solution-oriented approach program

control group (No Intervention: Usual Care at Community Mental Health Center)

NO INTERVENTION

No intervention will be applied to the control group

Interventions

solution-oriented approach program BEHAVIORAL

The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.

experimental group (Solution-Focused Approach Program)

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
• Being between 18 and 65 years of age,
• Being literate and verbally communicative,
• Being clinically stable (not exhibiting symptoms of acute psychosis),
• Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
• Being cognitively competent enough to participate in individual interviews during the research process,
• Being an individual currently receiving psychiatric treatment and taking medication,
• Agreeing to participate voluntarily in the study and signing a written informed consent form.

Sponsors & Collaborators

• Muş Alparslan University: lead

Study Sites (1)

Community Mental Health Center

Muş, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Treatment Adherence and Compliance; Schizophrenia

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Central Study Contacts

Fatih Şahin, dr

CONTACT

0534 688 1634; fatih.sahin@alparslan.edu.tr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: doctor

Study Record Dates

• First Submitted: August 6, 2025
• First Posted: August 27, 2025
• Study Start: January 1, 2025
• Primary Completion: February 25, 2025
• Study Completion: October 25, 2025
• Last Updated: August 27, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)